Vir Biotechnology Inc. (NASDAQ: VIR) reported Q1 EPS of ($0.88), $0.01 worse than the analyst estimate of ($0.87). Revenue for the quarter came in at $3.03 million versus the consensus estimate of $13.65 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.